和平药房连锁经营战略及实施策略研究

重庆大学硕士学位论文和平药房连锁经营战略及实施策略研究姓名：张静申请学位级别：硕士专业：工商管理指导教师：但斌20051001IWTO“”VRIOSWOT——“”VRIOSWOT(BPR)IIABSTRACTChainbusinesseshavealonghistoryandmoreresearchinourcountry.ButstudiesofdrugretailChainareless.AfterChinajoinedinWTOandnationalhospitalizationinsurancesysteminnovated,drugretailismoreandmorefurious.Theauthorresearchedalargerstatecompany,assheworkfor,whichisengagedindrugretailChain,tohelpandadvicefordomesticchaindrugstoresdevelopmentinthefuture.Firstly,thestudyintroducesconceptionofchainbusinessanditscharacteristic.TheauthorillustratesAmericandrugstoresdevelopment,compareandanalysesrelevantresearchofdomesticandinternationaldrugchainbusinesscontrastivelyincurrentsituation.ThencombiningPotter’sTheFiveForcesModel,adoptVRIOanalysistechnicalframeandenterprisevaluechaintheorytoanalyzePeaceDrugstorescompetitionkeycores.TherecombinationSWOTanalysis,exhaustivelyelaboratedthePeaceDrugstoresstrategyreformingcountermeasurechoiceaswellasthePeaceDrugstoresvaluechainmanagementandthechainmanagementstrategy.ItemphaticallyanalyzePeaceDrugstores’supportsystemofChainbusinessstratagem(e.g.marketing,distribution,suppliersalliance,informationsystem,humanresource,brand),anditsimplementationstrategy(e.g.stratagemofbrand,enterprisecultureconstruction,BusinessProcessRecombination(BPR),costcontrolstrategy,qualityassurancestrategy,customersloyaltydevelopment),toattempttofindabenefittrendaboutimplementationChainbusinessstratagem.Finally,thestudyaddressessomequestionsstillexistinimplementationofChainbusinessstratagemandgivesomefeasibleadvice.Keywords:Chain,Drug,Strategy,Implementingtactic1111.1WTO[17]()1.21.2.1“Chain”CIS()(ChainRegularchain,Directchain.)(Franchisechain)(VoluntaryChain)[1]185518652512“”15%20%1987·“”2010201520051.2.231.2.3(1),,,2000,Walgreens4330,320163200,18(2)13,13.1516RiteAidRiteAid,24(3)“”:80,,30%20%,40%-50%(4)(IT)[8]141.1Table1.1TheCompareofChainDrugstorescale(ChinavsAmerica)()()1342168.8Walgreens4335325.17815218.2Walgreens4335325.120041.2Table1.2thesituationdrugchaintradedevelopmentcomparison(ChinavsAmerican).10%49%IT15,[9]1.11.21.31.3.170[1020][2126][27]1.3.1.1NACDS4202050250001995560019991100019903200019982100030%1990130019997000199025001999500016(1)(2)[28]65%OTC35%1/1070%(3)(4)(5)—20%30%40%50%(6)INTERNET()()()()1.3.1.2[29]50(1)31.2%24.6%22.7%21.5%(2)2.647720%-25%17501.3.21.3.2.11949-198085%15%-20-2090201998——[30]201996——20001810%30%20%(1)——(2)WTO199520045001614020001919.4%1.3.2.2,,,(1)(2)30%10%110[31](3)2001121112004161.51818(4)(5)ITPOSMIS(6)[32](7)1.412“”VRIOSWOT11134(BPR)521222.12.1.1501997131998718120000CQM1994195019972019971317051997503420047.8151998GSP2420014GSP20047GSP2132.1.22.12.1Figure2.1DiagramofPeaceDrugstoresOrganization2.2·[33][34]122OTC32143452.2Fig.2.2TheFiveForcesModel2.2.112/2152.2.2442004GSP4490%900010002.2.32.2.42.2.52.32.3.1(1)1)216,,,,2)199612,:,,198950%—80%,,(2),217199763003000(3)1859140200019105002001~20045002019338019871000902184000Walgreens433020043251998102200068%19975100%199710,2192.3.2SWOT(Strengths,Weakness,Opportunities,andThreats)2.3.2.1(S)(1)(2)(3)—199419505.41.12831040000100(4)2.3.2.2(W)(1)(2)(3)29(4)2202.3.2.3(O)(1)(2)(3)2.3.2.4(T)(1)200240-45%(2)(3)(4)2.3.2.5SWOTSWOT2.1SWOTSWOTSOWO2212.1SWOTTable2.1SWOTAnalysisMatrix—S(1)(2)(3)—(4)—W(1)(2)(3)(4)—O(1)(2)SO(1)(2)WO(1)(2)—T(1)(2)(3)(4)ST(1)(2)222-2.3.3120070%50%2232.42.4.1VCs[35][36][37][38]·1985“”[35]“”2.3224MIS2.3Figure2.3PeaceDrugstoreValueChainAnalysis2.4.2,,,,,,225,,,,2.4.2.1(1)200463101001)2)OTC3),(2)2500300032263404-52.4.2.22.4.2.31-22.4.3“”·1990·[39]227·2282.4.4CQM2.42.4CQMFigure2.4CQMCompanyOperationDept.OrganizationCQM22919972000SWOT33033.13.1.1(1)1700(2)1)2)3)3313.1.2,“”2/33.23.2.1(1)20008332,770006500200005001)2)3)2004454-5(2)1)“”24242)200433210978429489211255507661301502401352004576412303.2.23332003“”“”“”3.2.3()2002881.8835——5003.3[40]ABCDA151%5.7%42.5%2000334B17%25%30%3.41999125005003.519978(1)1)“”2)3353)“”2000“”4)5)1999M100M200M30011066)7)“”(2)1)3362)3)“”4)5)“”3.619971999“”“”“”“”“”“”20024“”2000“”20039200220044“••”43744.1(1)“”“”CI1)CI2)“”“”“”“”243)4)438(2)“”(3)2002“”84394.1Table4.1Double-BrandStratagem4.2··“10”[41](1)440(2)“”(3)(4)CI(5)1)2)3)“”441“”4.3(BPR)·(BusinessProcessReengineering,BPR)“”[42](1)(2),(3)1)2)3)[43]4424.3.1(1)30(2)1)2)3)4)20-305)6)40-507)3,(3)1)2)4434.3.2(1)(2),,(3)20-30(4)404-54.4[44]4.4.12063%2005130292005444,4.4.218354.4.320031164404-5304.5,GSP1998117GSP2001GSP4454.6[45][46]“”(1)1)2)3)4)5)(2)1)2),3)“”446(3)“”“”“”“”100%100%“”;“”“”124.74.7.1—1)2)3)4)4474.7.22000020011999720037.340%30%50%500150025004.7.3(1)5004481)30102)OTC2003OTCOTC1-1050253)OTC(2)1)2)54955.15.1.1199751397389887991782000287200131020027232003101320041705315.1.219970.519981.119992.320004.620015.820026.520037.320047.85.119971998199920002001200220032004501102304605806507307801387178287310723101317055.21997550“”“”“”“”“”“”20024“”2000“”200311142003“12”20044“··”5.35.3.1(1)1)2)3)4)“”5)6)7)(2)1)2)3)5514)5)6)5.3.22005“”2005“”2005(1)(2)(3)(4)1234565.3.3(1)(2)(3)(4)552(5)(6)(7)(8)(9)5.3.4(1)CVS25%553(2)1)2)3)4)(20052302004125.6383%)(20053520043—6